Хирургическое лечение рака тела матки

Автор: Нечушкина В.М., Морхов К.Ю., Кузнецов В.В.

Журнал: Злокачественные опухоли @malignanttumors

Статья в выпуске: 3 (10), 2014 года.

Бесплатный доступ

Статья посвящена одному из наиболее дискуссионных вопросов современной онкогинекологии - вмешательствам на регионарных лимфатических узлах при раке тела матки. Рассмотрены аргументы их сторонников и противников.

Рак тела матки, тазовая лимфаденэктомия, поясничная лимфаденэктомия

Короткий адрес: https://sciup.org/14045506

IDR: 14045506

Список литературы Хирургическое лечение рака тела матки

GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide/Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M.//IARC CancerBase. -N 10. -Lyon, France: International Agency for Research on Cancer, 2010. -URL: http://globocan.iarc.fr (дата обращения 15.05.2012)
cases of stage I endometrial carcinoma: a clinicopathological analysis/Marziale P., Atlante G., Pozzi M., Diotallevi F., Iacovelli A.//Gynecol. Oncol. -1989. -Vol. 32, N 3. -P. 278-281
Carcinoma of the Corpus Uteri/Creasman W. T., Odicino F., Maisonneuve P., Quinn M. A., Beller U., Benedet J. L., Heintz A. P. M., Ngan H. Y. S., Pecorelli S.//Int. J. Gynaecol. Obstet. -2006. -Vol. 95 (suppl. 1). -P. S105-S144
Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report/Creasman W. T., Boronow R. C., Morrow C. P., DiSaia P. J., Blessing J.//Gynecol. Oncol. -1976. -Vol. 4, N 3. -P. 239-243
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study/Boronow R. C., Morrow C. P., Creasman W. T., DiSaia P. J., Silverberg S. G., Miller A., Blessing J. A.//Obstet. Gynecol. -1984. -Vol. 63, N 6. -P. 825-832
Surgical pathologic spread patterns of endometrial Cancer. A Gynecologic Oncology Group Study/Creasman W. T., Morrow C. P., Bundy B. N., Homesley H. D., Graham J. E., Heller P. B.//Cancer. -1987. -Vol. 60, N 8 (suppl.). -P. 2035-2041
Aalders J. G., Thomas G. Endometrial cancer-revisiting the importance of pelvic and para-aortic lymph nodes//Gynecol. Oncol. -2007. -Vol. 104. -P. 222-231
Orr J. W., Holimon J., Orr P. Stage I corpus cancer: is teletherapy necessary//Am. J. Obstet. Gynecol. -1997. -Vol. 176. -P. 777-789
Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma/Homesley H. D., Kadar N., Barrett R. J., Lentz S.S./Am. J. Obstet. Gynecol. -1992. -Vol. 167. -P. 1225-1230
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients/Mariani A., Dowdy S., Cliby W., Haddock M. G., Keeney G. L., Lesnick T. G., Podratz K. C.//Gynecol. Oncol. -2006. -Vol. 101. -P. 200-208
Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma/Creutzberg C. L., van Putten W. L., Koper P. C., Lybeert M. L., Jobsen J. J., Warlam-Rodenhuis C. C., De Winter K. A., Lutgens L. C., van den Bergh A. C., van de Steen-Banasik E., Beerman H.,van Lent M.//Lancet. -2000. -Vol. 355. -P. 1404-1411
Trimble E., Kosary C., Park R. Lymph node sampling and survival in endometrial cancer//Gynecol. Oncol. -1998. -Vol. 71. -P. 340-343
COSA-NZ-UK Endometrial Cancer Study Groups. Pelvic lymphadenectomy in high-risk endometrial cancer//Int. J. Gynecol. Cancer. -1996. -Vol. 6. -P. 102-107
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study/ASTEC study group, Kitchener H., Swart A. M., Qian Q., Amos C., Parmar M. K.//Lancet. -2009.-Vol. 373, N 9658. -P. 125-136
Creasman W. T. The current status of lymphadenectomy in the management of endometrial cancer//Womens Health (Lond. Engl). -2011. -Vol. 7, N 1. -P. 33-35
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis // Todo Y., Kato H., Kaneuchi M., Watari H., Takeda M., Sakuragi N. // Lancet. - 2010. - Vol. 375, N 9721. - P. 1165-1172
Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma/Suzuki Y., Todo Y., Okamoto K., Minobe S., Kato H.//Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23-26 Oct 2010. -Abs. 1433
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial/Benedetti Panici P., Basile S., Maneschi F., Alberto Lissoni A., Signorelli M., Scambia G., Angioli R., Tateo S., Mangili G., Katsaros D., Garozzo G., Campagnutta E., Donadello N., Greggi S., Melpignano M., Raspagliesi F., Ragni N., Cormio G., Grassi R., Franchi M., Giannarelli D., Fossati R., Torri V., Amoroso M., Croce C., Mangioni C.//J. Natl. Cancer Inst. -2008. -Vol. 100, N 23. -P. 1707-1716
Outcome of high-risk stage IC, grade 3 compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial/Creutzberg C., van Putten W., Warlam-Rodenhuis C. C., van den Bergh A. C., de Winter K. A., Koper P. C., Lybeert M. L., Slot A., Lutgens L. C., Stenfert Kroese M. C., Beerman H., van Lent M; Postoperative Radiation Therapy in Endometrial Carcinoma Trial//J. Clin. Oncol. -2004. -Vol. 22. -P. 1234-1241
Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy/Onda T., Yoshikawa H., Mizutani K., Mishima M., Yokota H., Nagano H., Ozaki Y., Murakami A., Ueda K., Taketani Y.//Br. J. Cancer. -1997. -Vol. 75. -P. 1836-1841
Analysis of FIGO stage IIIc endometrial cancer patients/McMeekin D. S., Lashbrook D., Gold M., Johnson G., Walker J. L., Mannel R.//Gynecol. Oncol. -2001.-Vol. 81. -P. 273-278
FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy/Nelson G., Randall M., Sutton G., Moore D., Hurteau J., Look K.//Gynecol. Oncol. -1999. -Vol. 75. -P. 211-214
Relationship between surgical-pathological risk factors and outcome in clinical stages I and II carcinoma of the endometrium. A Gynecologic Oncology Group study/Morrow C. P., Bundy B. N., Kumar R. J., Creasman W. T., Heller P., Homesley H. D., Graham J. E.//Gynecol. Oncol. -1991. -Vol. 40, N 1. -P. 55-65
Kim Y., Niloff J. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy//Obstet. Gynecol. -1993. -Vol. 82. -P. 175-180
Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer/Faught W., Krepart G., Loctocki R., Heywood M.//Gynecol Oncol. -1994. -Vol. 55. -P. 51-55
Uterine papillary serous carcinoma: patterns of metastatic spread/Goff B., Kato D., Schmidt R., Ek M., Ferry J. A., Muntz H. G., Cain J. M., Tamimi H. K., Figge D. C., Greer B. E.//Gynecol. Oncol. -1994. -Vol. 54. -P. 264-268
Podratz K. C., Mariani A., Webb M. Staging and therapeutic value of lymphadenenctomy in endometrial cancer//Gynecol. Oncol. -1998. -Vol. 70. -P. 163-164
Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma/Doering D. L., Barnhill D. R., Weiser E. B., Burke T. W., Woodward J. E., Park R. C.//Obstet. Gynecol. -1989. -Vol. 74. -P. 930-933
Clinical value of intraoperative gross examination in endometrial cancer/Franchi M., Ghezzi F., Melpigano M., Cherchi P. L., Scarabelli C., Apolloni C., Zanaboni F.//Gynecol. Oncol. -2000. -Vol. 76. -P. 357-361
Goff B. A., Riche L. W. Assessment of depth of myometrial invasion in endometrial adenocarcinoma//Gynecol. Oncol. -1990. -Vol. 38. -P. 46-48
A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer/Case A. S., Rocconi R. P., Straughn J. M., Jr., Conner M., Novak L., Wang W., Huh W. K.//Obstet. Gynecol. -2006. -Vol. 108. -P. 1375-1379
Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer/Frumovitz M., Slomovitz B. M., Singh D. K., Broaddus R. R., Abrams J., Sun C. C., Bevers M., Bodurka D. C.//J. Am. Coll. Surg. -2004. -Vol. 199, N 3. -P. 388-393
Predictors of final histology in patients with endometrial cancer/Frumovitz M., Singh D. K., Meyer L., Smith D. H., Wertheim I., Resnik E., Bodurka D. C.//Gynecol. Oncol. -2004. -Vol. 95, N 3. -P. 463-468
Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies/Arango H. A., Hoffman M. S., Roberts W. S., DeCesare S. L., Fiorica J. V., Drake J.//Obstet. Gynecol. -2000. -Vol. 95, N 4. -P. 553-556
Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group study/Singh M., Zaino R., Filiaci V., Leslie K. K.//Gynecol. Oncol. -2007. -Vol. 106, N 2. -P. 325-333
Therapeutic role of lymph node resection in endometrioid corpus Cancer: a study of 12,333 patients/Chan J. K., Cheung M. K., Huh W. K., Osann K., Husain A., Teng N. N., Kapp D. S.//Cancer. -2006. -Vol. 107, N 8. -P. 1823-1830
Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis: a Gynecologic Oncology Group study/Creasman W. T., Zaino R., Major F. L., DiSaia P. J., Hatch K. D., Homesley H. D.//Am. J. Obstet. Gynecol. -1998. -Vol. 178, N 1. -P. 62-65
Surgical staging of early invasive epithelial ovarian tumors/Leblanc E., Querleu D., Narducci F., Chauvet M. P., Chevalier A., Lesoin A., Vennin P., Taieb S.//Semin. Surg. Oncol. -2000. -Vol. 19. -P. 36-41
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center/Abu-Rustum N., Alektiar K., Iasonos A., Lev G., Sonoda Y., Aghajanian C., Chi D. S., Barakat R. R.//Gynecol. Oncol. -2006. -Vol. 103, N 2. -P. 714-718
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial cancer/Cohn D., Huh D., Fowler J., Straughn J. M., Jr.//Obstet. Gynecol. -2007. -Vol. 109, N 6. -P. 1388-1395
Comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact/Barnes M. N., Roland P., Straughn M., Kilgore L. C., Alvarez R. D., Partridge E. E.//Gynecol. Oncol. -1999. -Vol. 74, N 3. -P. 443-447
Stage IVb endometrial carcinoma: the role of cytoreductive surgery and determinants of survival/Bristow R. E., Zerbe M. J., Rosenshein N. B., Grumbine F. C., Montz F. J.//Gynecol. Oncol. -2000. -Vol. 78, N 2.-P. 85-91
Surgical stage IV endometrial carcinoma: a study of 47 cases/Goff B. A, Goodman A., Muntz H. G., Fuller A. F., Jr, Nikrui N., Rice L. W.//Gynecol. Oncol. -1994. -Vol. 52, N 2. -P. 237-240
The role of surgical cytoreductive surgery in stage IV endometrial carcinoma/Chi D. S., Welshinger M., Venkatraman E. S., Barakat R. R.//Gynecol. Oncol. -1997. -Vol. 67, N 1. -P. 56-60
Nodal distribution and its significance in FIGO stage III endometrial cancer/McMeekin D. S., Lashbrook D., Gold M., Scribner D. R., Kamelle S., Tillmanns T. D., Mannel R.//Gynecol. Oncol. -2001. -Vol. 82, N 2. -P. 375-379
Incidence and location of para-aortic lymph node metastases in gynecologic malignancies/Flanagan C., Mannel R., Walker J., Johnson G. A.//J. Am. Coll. Surg. -1995. -Vol. 181, N 1. -P. 72-74
Lymphadenectomy in endometrioid uterine Cancer staging: how many lymph nodes are enough? A study of 11,443 patients/Chan J. K., Urban R., Cheung M. K., Shin J. Y., Husain A., Teng N. N., Berek J. S., Walker J. L., Kapp D. S., Osann K.//Cancer. -2007. -Vol. 109, N 12. -P. 2454-2460
Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?/Hsieh C. H., Chang Chien C. C., Lin H., Huang E. Y., Huang C. C., Lan K. C., Chang S. Y.//Gynecol. Oncol. -2002. -Vol. 86, N 1. -P. 28-33
A clinical and pathologicstudy on para-aortic lymph node metastasis in endometrial carcinoma/Hirahatake K., Hareyama H., Sakuragi N., Nishiya M., Makinoda S., Fujimoto S.//J. Surg. Oncol. -1997. -Vol. 65, N 2. -P. 82-87
Otsuka I., Kubota T., Aso T. Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy//Br. J. Cancer. -2002. -Vol. 87, N 4. -P. 377-380
Resection of lymph node metastases influences survival in stage IIIC endometrial cancer/Havrilesky L. J., Cragun J., Calingaert B., Synan I., Secord A. A., Soper J. T., Clarke-Pearson D. L., Berchuck A.//Gynecol. Oncol. -2005. -Vol. 99, N 3. -P. 689-695
Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes/Chuang L., Burke T., Tornos C., Marino B. D., Mitchell M. F., Tortolero-Luna G., Levenback C., Morris M., Gershenson D. M.//Gynecol. Oncol. -1995. -Vol. 58, N 2. -P. 189-193
Potential therapeutic role of para-aortic lymphadenectomy in node positive endometrial cancer/Mariani A., Webb M., Galli L., Podratz K. C.//Gynecol. Oncol. -2000. -Vol. 76, N 3. -P. 348-356
Detailed analysis of endometrial cancer patients who underwent resection of upper and lower para-aortic nodes during a lymphadenectomy/Koc S., Ozer S., Turan T., Keskin H. L., Ozfuttu A., Boran N., Tulunay G., Kose M. F.//Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23-26 Oct 2010. -Abs. 1486
Systematic pelvic and paraaortic lymphadenectomy in endometrial cancer: lymph node metastasis pattern and identification of predictive factors for lymph-node status/El-Balat A., Fotopoulou C., Sehouli J., Heitz F., Muallem M. Z., Harter P., Kratschell R., du Bois A.//Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23-26 Oct 2010. -Abs. 160
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling/Kilgore L. C., Partridge E. E., Alvarez R. D., Austin J. M., Shingleton H. M., Noojin F., 3rd, Conner W.//Gynecol. Oncol. -1995. -Vol. 56, N 1. -P. 29-33
Pelvic lymphadenectomy in the surgical treatment of endometrial cancer/Girardi F., Petru E., Heydarfadai M., Haas J., Winter R.//Gynecol. Oncol. -1993. -Vol. 49, N 2. -P. 177-180
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer/Cragun J. M., Havrilesky L. J., Calingaert B., Synan I., Secord A. A., Soper J. T., Clarke-Pearson D. L., Berchuck A.//J. Clin. Oncol. -2005. -Vol. 23, N 16. -P. 3668-3675
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study/Keys H. M., Roberts J. A., Brunetto V. L., Zaino R. J., Spirtos N. M., Bloss J. D., Pearlman A., Maiman M. A., Bell J. G.; Gynecologic Oncology Group//Gynecol. Oncol. -2004. -Vol. 92, N 3. -P. 744-751
Orton J., Blake P. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomized MRC ASTEC and NCIC CTG EN.5 trial//J. Clin. Oncol. -2007. -Vol. 25, N 182. -Abs. 5504
Long-term outcomes after pelvic radiation for early-stage endometrial cancer/Onsrud M., Cvancarova M., Hellebust T. P., Trope C. G., Kristensen G. B., Lindemann K.//J. Clin. Oncol. -2013. -Vol. 31, N 31. -P. 3951-3956
Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches/Barakat R. R., Lev G., Hummer A., Sonoda Y., Chi D. S., Alektiar K. M., Abu-Rustum N. R.//Gynecol. Oncol. -2007. -Vol. 105, N 1. -P. 150-156
The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer/Goudge C., Bernhard S., Cloven N., Morris P.//Gynecol. Oncol. -2004. -Vol. 93, N 2. -P. 536-539
Fanning J., Nanavati P., Hilgers R. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node positive tumors//Obstet. Gynecol. -1996. -Vol. 87. -P. 1041-1044
Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma/Mohan D., Samuels M., Selim M., Shalodi A. D., Ellis R. J., Samuels J. R., Yun H. J.//Gynecol. Oncol. -1998. -Vol. 70, N 2. -P. 165-171

Еще

Статья научная